(2-Methylbenzo[d]oxazol-6-yl)boronic acid, 95.0%, 250mg

4-Methoxy-2-(piperidin-4-yloxy)pyridinedihydrochloride, 1g

2-amino-4-(thiophen-3-yl)benzoic acid, 95.0%, 250mg

Ammonium Formate>98.0%(T)200g

1-(Methoxymethyl)-2-nitrobenzene, 98%, 10g

(S)-5-OXOPIPERIDINE-2-CARBOXYLIC ACID HCL, 95.0%, 250mg

2,6-Dibromo-N,N'-di-n-octyl-1,8:4,5-naphthalenetetracarboxdiimide>98.0%(HPLC)5g

(R)-(2,3-Dimethoxyphenyl)(1-(4-fluorophenethyl)piperidin-4-yl)methanol, 95.0%, 100mg

Acryloxypropyl T-structure siloxane, 10-30 cSt, 100g

4-Bromo-2-fluoro-3-methylaniline, 97%, 500mg

Trans-2-(methoxycarbonyl)cyclobutanecarboxylic acid, 95.0%, 10g

4-Acetyl-3-ethyl-5-methyl-1h-pyrrole-2-carboxylic acid, 95%, 50mg

3-(ethoxycarbonyl)-5-methyl-1-(4-phenoxyphenyl)-4,5-dihydro-1H-pyrazole-5-carboxylic acid, 95.0%, 1g